Article information
Full text is only aviable in PDF
REFERENCES
[1]
P Bresser, L van Alphen, HM Jansen, R Lutter.
Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 162 (2000), pp. 947-952
[2]
N Soler, S Ewig, A Torres, X Filella, J González, A Xaubet.
Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease.
Eur Respir J, 14 (1999), pp. 1015-1022
[3]
JT MacFarlane, A Colville, A Guion, RM MacFarlane, DH Rose.
Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community.
Lancet, 341 (1993), pp. 511-514
[4]
AF Connors, NV Dawson, C Thomas, FE Harrell Jr, N Desbiens, WJ Fulkerson, et al.
Outcomes following acute exacerbation of severe chronic obstructive lung disease.
Am J Respir Crit Care Med, 154 (1996), pp. 959-967
[5]
TAR Seemugal, GC Donaldson, A Bhowmik, DJ Jeffries, JA Wedzicha.
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 161 (2000), pp. 1608-1613
[6]
RE Kanner, NR Anthonisen, JE Connett, for the Lung Health Study Research Group.
Lower respiratory illnesses promote FEV1 decline in current smokers but not ex smokers with mild chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 164 (2001), pp. 358-364
[7]
GC Donaldson, TAR Seemugal, A Bhowmik, JA Wedzicha.
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.
Thorax, 57 (2002), pp. 847-852
[8]
J MacFarlane, J Prewett, D Rose, P Gard, R Cunningham, P Saikku, et al.
Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community.
Thorax, 56 (2001), pp. 109-114
[9]
N Soler, A Torres, S Ewig, J González, R Celis, M El-Ebiary, et al.
Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.
Am J Respir Crit Care Med, 157 (1998), pp. 1498-1505
[10]
E Monsó, J Ruiz, A Rosell, J Manterola, J Fiz, J Morera, et al.
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.
Am J Respir Crit Care Med, 152 (1995), pp. 1316-1320
[11]
M Miravitlles, C Espinosa, E Fernández-Laso, JA Martos, JA Maldonado, M Gallego, et al.
Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD.
Chest, 116 (1999), pp. 40-46
[12]
E Monsó, J García-Aymerich, N Soler, E Farrero, MA Félez, JM Antó, et al.
Bacterial infection in exacerbated COPD with changes in sputum characteristics.
Epidemiol Infect, 131 (2003), pp. 799-804
[13]
M Woodhead, G Gialdroni Grassi, GJ Huchon, P Léophonte, F Manresa, T Schaberg.
Use of investigations in lower respiratory tract infection in the community: a European survey.
Eur Respir J, 9 (1996), pp. 1596-1600
[14]
S Saint, S Bent, E Vittinghoff, D Grady.
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis.
JAMA, 273 (1995), pp. 957-960
[15]
RF Grossman.
The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD.
Chest, 113 (1998), pp. 249S55S
[16]
SEPAR.
Conferencia de consenso sobre enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 39 (2003), pp. 1-47
[17]
P Montravers, JY Fagon, J Chastre, M Lecso, MC Dombret, JL Trouillet, et al.
Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia.
Am Rev Respir Dis, 147 (1993), pp. 38-44
[18]
S Chodosh, J McCarty, S Farkas, M Drehobl, R Tosiello, M Shan, et al.
Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis.
Clin Infect Dis, 27 (1998), pp. 722-729
[19]
S Chodosh, A Schreurs, G Siami, HW Barkman Jr, A Anzueto, M Shan, et al.
Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis.
Clin Infect Dis, 27 (1998), pp. 730-738
[20]
E Monsó, A Rosell, G Bonet, J Manterola, PJ Cardona, J Ruiz, et al.
Risk factors for lower airway bacterial colonization in chronic bronchitis.
Eur Respir J, 13 (1999), pp. 338-342
[21]
R Zalacaín, V Sobradillo, J Amilibia, J Barrón, V Achótegui, JI Pijoan, et al.
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.
Eur Respir J, 13 (1999), pp. 343-348
[22]
H Lomholt, L van Alphen, M Kilian.
Antigenic variation in immunoglobulin A1 proteases among sequential isolates of Haemophilus influenzae for healthy children and patients with chronic obstructive pulmonary disease.
Infect Immun, 61 (1993), pp. 4575-4581
[23]
L van Alphen, HM Jansen, J Dankert.
Virulence factors in the colonization and persistence of bacteria in the airways.
Am J Respir Crit Care Med, 151 (1995), pp. 2094-2099
[24]
K Groeneveld, L van Alphen, PP Eijk, G Visschers, HM Jansen, HC Zanen.
Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence.
J Infect Dis, 161 (1990), pp. 512-517
[25]
I Patel, TAR Seemungal, M Wilks, SJ Lloyd-Owen, GC Donaldson, JA Wedzicha.
Relationship between bacterial colonization and the frequency, character and severity of COPD exacerbations.
Thorax, 57 (2002), pp. 759-764
[26]
S Sethi, N Evans, BJB Grant, TF Murphy.
New strains ob bacteria and exacerbations of chronic obstructive pulmonary disease.
N Engl J Med, 347 (2002), pp. 465-471
[27]
A Rosell.
Estudio de la población bacteriana endobronquial en la enfermedad pulmonar obstructiva crónica [doctoral dissertation], Universidad Autónomade Barcelona, (2000),
[28]
RA Stockley, C O'Brien, A Pye, SL Hill.
Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.
Chest, 117 (2000), pp. 1638-1645
[29]
AT Hill, EJ Campbell, SL Hill, DL Bayley, RA Stockley.
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.
Am J Med, 109 (2000), pp. 288-295
[30]
AJ White, S Gompertz, DL Bayley, SL Hill, C O'Brien, I Unsal, et al.
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis.
Thorax, 58 (2003), pp. 680-685
[31]
TMA Wilkinson, IS Patel, M Wilks, GC Donaldson, JA Wedzicha.
Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 167 (2003), pp. 1090-1095
This paper was written with support from a grant from Red Respira, ISCIII-RTIC-03/11.
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
